Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate.
about
Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatmentsClonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodiesHumoral immune response in patients with cerebral parenchymal cysticercosis treated with praziquantelAnti-HIV antibodies in the CSF of AIDS patients: a serological and immunoblotting study.Validation of serum markers for blood-brain barrier disruption in traumatic brain injury.Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis.Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patientsCerebrospinal fluid (CSF) analyses in HIV-1 primary neurological disease.Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.Main adult herpes virus infections of the CNS.A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosisIntrathecal synthesis of anti-mycobacterial antibodies in patients with tuberculous meningitis. An immunoblotting study.Antibody synthesis within the central nervous system: comparisons of CSF IgG indices and electrophoresis.Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases.Diagnostic usefulness of cerebrospinal fluid in multiple sclerosis.The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.HTLV-I-associated myelopathy: oligoclonal immunoglobulin G bands contain anti-HTLV-I p24 antibody.IgG production within the central nervous system: a critical review of proposed formulae.The current status of multiple sclerosis intra-blood-brain-barrier IgG synthesis.The effect of systemic inflammation on human brain barrier functionEnhancement of central nervous system remyelination in immune and non-immune experimental models of demyelination.Passage of intravenous immunoglobulin and interaction with the CNS.Increased beta 2-microglobulin in CSF of multiple sclerosis.An isoelectric focusing study in herpes simplex virus encephalitis.Intraventricular interferon in a case of subacute sclerosing panencephalitis.Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases.Herpes simplex virus type 2 meningitis without genital lesions: an immunoblot study.Multiple sclerosis intra-blood-brain-barrier IgG synthesis: effect of pulse intravenous and intrathecal corticosteroids.Late onset globoid leukodystrophy: unusual clinical and CSF findings.The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.The basis of intra-blood-brain-barrier IgG synthesis.Soluble CD8 and ICAM-1 in serum and CSF of MS patients treated with 6-methylprednisolone.Search for HTLV-I and LAV/HTLV-III antibodies in serum and CSF of multiple sclerosis patients.
P2860
Q26851694-513A329D-9A4B-4DBD-805E-2667E041A033Q28282500-C52D1678-EC4E-445D-8212-33301CE3D484Q33629739-5CE573CA-D264-4FA8-AA06-7DC22818DE16Q33631223-5A87CB5B-AE8A-4DCA-9A29-9E0AD80516BFQ33657728-638EC232-9AFB-4423-9CA0-BED57C135FA3Q33732864-34A0F209-9E40-4498-811B-25213CDF5A2BQ34052870-FB64B617-3247-4DCB-B189-D8EA79592651Q35585366-FB6E61A4-34D3-4D5C-9893-9503EFF1AE2CQ35654754-A416F5F8-EC8D-4F16-BF1A-4AB2C706070BQ35769109-A5D327BF-7E33-4216-AD2D-CDBFAC5F9229Q36233543-9EA069ED-C740-4F04-A2BC-392B1EDC7D64Q36891696-DED1B668-068A-42E4-9DF7-476D1A9AA27CQ36939538-5F8A9054-5A95-47BA-9665-751D5623C554Q37169484-7471759A-F562-4C3A-87BD-5D92F2B85293Q37206262-4E9D3F14-8F5C-4D4C-88D6-3A7DF816F6ECQ37340919-67243F3D-BDAD-46FA-A1B0-2EF259C17658Q38092972-147B8E7E-DD78-4901-BAC3-84518632C04EQ39033631-6337551A-2BB2-4B27-994C-1BB576CE1C05Q39858742-455D259B-3364-4A57-AC3B-454FA98B8208Q40202336-D93AC7D3-E8E5-4430-B51B-AD6429297701Q40465097-2279BFBB-5141-478E-9EBC-03310155F5EEQ41589686-12496BC7-AD53-4739-88B6-E65448C1D56EQ41663237-06AEA39B-ADD7-40DA-A220-975728C958DDQ42588514-4DC727BD-4696-4550-A6FC-D80D7D089B26Q44804340-C096DD81-3E68-4B7A-8EAF-4EB085F0ACD0Q44937267-11165C25-DEC2-4118-9279-6613DB2241DBQ45110047-418E80C6-C107-458B-8E9C-CFFDF28724D9Q45850704-94EB77D0-26E3-4130-90BD-C9D631A2269BQ45963115-16456014-CE57-4758-85F3-761E2F79517FQ46158741-A5358D8E-BDFD-42A0-B70F-2FD090B72459Q47109739-82BD0368-A9E8-46AD-965B-E97FF76D78DDQ48554203-5D114B18-F512-4D7B-AEA6-850513A9D2F8Q48713158-CE68B811-AEC7-4E84-82D4-ADA4CC6273A5Q55243808-3F5457C7-2C3F-472B-BD73-049063302269
P2860
Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh
1980年學術文章
@zh-hant
name
Multiple sclerosis: measuremen ...... ous system IgG synthesis rate.
@en
Multiple sclerosis: measuremen ...... ous system IgG synthesis rate.
@nl
type
label
Multiple sclerosis: measuremen ...... ous system IgG synthesis rate.
@en
Multiple sclerosis: measuremen ...... ous system IgG synthesis rate.
@nl
prefLabel
Multiple sclerosis: measuremen ...... ous system IgG synthesis rate.
@en
Multiple sclerosis: measuremen ...... ous system IgG synthesis rate.
@nl
P2093
P356
P1433
P1476
Multiple sclerosis: measuremen ...... ous system IgG synthesis rate.
@en
P2093
Fleming JO
Syndulko K
Tourtellotte WW
P304
P356
10.1212/WNL.30.3.240
P407
P577
1980-03-01T00:00:00Z